These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 1101819)

  • 1. Relation of beta-lactamase activity to antimicrobial susceptibility in Serratia marcescens.
    Tsang JC; Sansing GA; Miller MA
    Antimicrob Agents Chemother; 1975 Sep; 8(3):277-81. PubMed ID: 1101819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clavulanic acid on activity of beta-lactam antibiotics in Serratia marcescens isolates producing both a TEM beta-lactamase and a chromosomal cephalosporinase.
    Bush K; Flamm RK; Ohringer S; Singer SB; Summerill R; Bonner DP
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2203-8. PubMed ID: 1803992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. beta-Lactamases and resistance to penicillins and cephalosporins in Serratia marcescens.
    Farrar WE; O'dell NM
    J Infect Dis; 1976 Sep; 134(3):245-51. PubMed ID: 789784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-lactamase activity in Shigella sonnei.
    Prince A; Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):776-9. PubMed ID: 782355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA; Tawfik AF; Shibl AM
    Chemotherapy; 1995; 41(3):193-9. PubMed ID: 7656665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Susceptibility to beta-lactam antibiotics and production of beta-lactamase in Bacteroides fragilis.
    Olsson B; Dornbusch K; Nord CE
    Med Microbiol Immunol; 1977 Oct; 163(3):183-94. PubMed ID: 243112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli.
    Farrar WE; Newsome JK
    Am J Clin Pathol; 1976 Apr; 65(4):570-4. PubMed ID: 817594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility of Yersinia kristensenii strains to beta-lactam antibiotics.
    Bejar V; Calvo C; Ramos Cormenzana A
    Ann Inst Pasteur Microbiol (1985); 1986; 137A(2):169-77. PubMed ID: 3501272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iodometric assay method for beta-lactamase with various beta-lactam antibiotics as substrates.
    Sawai T; Takahashi I; Yamagishi S
    Antimicrob Agents Chemother; 1978 Jun; 13(6):910-3. PubMed ID: 677858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.
    Darland G; Birnbaum J
    Antimicrob Agents Chemother; 1977 Apr; 11(4):725-34. PubMed ID: 856025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of clinical isolates of Serratia marcescens.
    Alvarez JS; Regueiro B; Garrido MJ
    Antimicrob Agents Chemother; 1979 Oct; 16(4):523-4. PubMed ID: 391150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of beta-lactamase inhibitor combinations on Escherichia coli isolates exhibiting various patterns of resistance to beta-lactam agents.
    Vanjak D; Muller-Serieys C; Picard B; Bergogne-Berezin E; Lambert-Zechovsky N
    Eur J Clin Microbiol Infect Dis; 1995 Nov; 14(11):972-8. PubMed ID: 8654448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Lactamase activity in strains of Bacteroides melaninogenicus and Bacteroides oralis.
    Salyers AA; Wong J; Wilkins TD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):142-6. PubMed ID: 13705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and prevalence of the different mechanisms of resistance to beta-lactam antibiotics in clinical isolates of Escherichia coli.
    Medeiros AA; Kent RL; O'Brien TF
    Antimicrob Agents Chemother; 1974 Dec; 6(6):791-801. PubMed ID: 4615632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of spontaneous resistant variants of Serratia marcescens selected in the presence of carbenicillin.
    Platt DJ; Sommerville JS; McGroarty JA
    J Antimicrob Chemother; 1983 Oct; 12(4):329-35. PubMed ID: 6358176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro antagonism by N-formimidoyl thienamycin and cefoxitin of second and third generation cephalosporins in Aeromonas hydrophila and Serratia marcescens.
    Miller MA; Finan M; Yousuf M
    J Antimicrob Chemother; 1983 Apr; 11(4):311-8. PubMed ID: 6343337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overproduced beta-lactamase and the outer-membrane barrier as resistance factors in Serratia marcescens highly resistant to beta-lactamase-stable beta-lactam antibiotics.
    Hechler U; van den Weghe M; Martin HH; Frère JM
    J Gen Microbiol; 1989 May; 135(5):1275-90. PubMed ID: 2695600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefamandole, cefoxitin, cefuroxime, and carbenicillin, alone and in combination with aminoglycosides against Serratia marcescens.
    Miller MA; Yousuf M; Griffin PS; Bartlett M; Crane JK
    Microbiol Immunol; 1979; 23(10):955-64. PubMed ID: 390321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the antibiotic resistance rates of
    Simsek M
    Niger J Clin Pract; 2019 Jan; 22(1):125-130. PubMed ID: 30666031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.